Osso VR, which uses VR simulations to train doctors and other medical professionals, raises $27M led by GSR Ventures
Dean Takahashi / VentureBeat :
Context & Ripple Effects
This round slots into a fast escalation for Osso VR: it raised a $14M Series A built on Oculus Quest headsets for surgical and medical device training in late 2020, and within nine months GSR Ventures-led capital nearly triples that raise. The arc continues after this story — by March 2022 the company pulls a $66M Series C led by Oak HC/FT, taking total funding to about $109M.
So this $27M is the middle beat where VR surgical training proves it can keep raising at accelerating sizes. It also fits a broader category moment: FundamentalVR raises $20M for cross-platform medical simulation a year later, Oxford VR applies simulation to mental health, and medical schools begin inserting the tech into their curriculums.
First-order effects
- Osso VR gets the capital to scale its Oculus Quest-based surgical training content and headset deployments beyond what the Series A funded, with GSR Ventures as lead backer.
Second-order effects
- Rival simulation platforms feel the category validating: FundamentalVR follows with a $20M EQT Life Sciences-led round, meaning buyers of medical training tech now face competing funded vendors rather than one pioneer.
Third-order effects
- If funding momentum holds — as it did through the Series C — VR training shifts from pilot novelty toward embedded infrastructure in hospitals and medical school curriculums, pressuring traditional cadaver- and apprenticeship-based training economics.
The trend: Medical VR is graduating from point-solution pilots into a funded platform category, with Osso VR's escalating rounds tracking the sector's move from headsets-as-demo to curricula-as-default.